Skip to content
lifestyle.floredechampagne.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Elanco Animal Health
Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility
August 26, 2026
Elanco’s CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species
August 19, 2026
Elanco Animal Health Reports Second Quarter 2026 Results
August 19, 2026
Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society’s Growing Needs
August 19, 2026
New Research Reveals Pet Spending as a “Protected Budget Item” for Owners, Fueling Industry Resilience
June 3, 2026
Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market
May 18, 2026
Elanco to Participate in Upcoming Investor Conferences
May 14, 2026
Elanco Animal Health Reports First Quarter 2026 Results
May 6, 2026
/C O R R E C T I O N — Elanco Animal Health/
April 28, 2026
Elanco’s Negasunt™ Powder (Coumaphos, Propoxur, Sulfanilamide Topical Powder) and Tanidil™ (Coumaphos, Propoxur) Receive Emergency Authorization for Use Against New World Screwworm in Livestock
April 27, 2026
1
2
Next Page
→